UK: Trials for 4 Treatments at Oxford University

According to the website of the “Randomised Evaluation of Covid-19 Therapy” project, there are 4 treatments being tested.

See website excerpt below

And see critique of this research here: http://covexit.com/oxford-recovery-evaluation-of-covid-19-therapy-flawed-against-hydroxychloroquine-and-dangerous-to-patients/

THIS NATIONAL CLINICAL TRIAL AIMS TO IDENTIFY TREATMENTS THAT MAY BE BENEFICIAL FOR ADULTS HOSPITALISED WITH CONFIRMED COVID-19

A range of potential treatments have been suggested for COVID-19 but nobody knows if any of them will turn out to be more effective in helping people recover than the usual standard of hospital care which all patients will receive. The RECOVERY Trial will begin by testing some of these suggested treatments: 

  • Lopinavir-Ritonavir (commonly used to treat HIV)
  • Low-dose Dexamethasone (a type of steroid, which is used in a range of conditions typically to reduce inflammation).
  • Hydroxychloroquine (related to an anti-malarial drug)
  • Inhaled interferon-beta1a (an antiviral drug; not currently in use in this trial)

Data from the trial will be regularly reviewed so that any effective treatment can be identified quickly and made available to all patients. The RECOVERY Trial team will constantly review information on new drugs and include promising ones in the trial.

Source: https://www.recoverytrial.net/

(Visited 163 times, 163 visits today)
>>  Interview with Dr Altino de Almeida - Part 2